AMDL | 合法醫療器材資訊網
TUSTIN, Calif., July 14 /PRNewswire-FirstCall/ -- (www.amdl.com) AMDL, Inc., a leading vertically integrated bio-pharmaceutical company with major operations in China and the US, announced that the AMDL-ELISA DR- 70(R) (FDP) test has been shown to be a useful test for the detection of cancer in clinical practice according to an independent study of 185 patients from the Medical Department II at the University Hospital in Frankfurt Germany. The results were published in the international medical research publication Alimentary Pharmacology & Therapeutics.
The purpose of this independent study was to evaluate the potential of the DR-70 ELISA (FDP) test as a detection test for gastrointestinal cancers that include, colorectal, esophageal, gallbladder, gastric, liver, pancreatic and intestinal cancers. Additionally, the quantitative value of DR-70 (FDP) was tested as a parameter for the progression of these...
Advantages of the AMDL-ELISA DR-70 (FDP ... | 合法醫療器材資訊網
Role of DR | 合法醫療器材資訊網
510(k) - AMDL-ELISA DR | 合法醫療器材資訊網
Clinical performance of the AMDL DR | 合法醫療器材資訊網
ELISA DR | 合法醫療器材資訊網
(PDF) Advantages of the AMDL | 合法醫療器材資訊網
The new DR | 合法醫療器材資訊網
AMDL | 合法醫療器材資訊網
華宇-腫瘤標記DR | 合法醫療器材資訊網
Advantages of the AMDL-ELISA DR | 合法醫療器材資訊網
【華宇-腫瘤標記DR-70酵素免疫分析診斷試劑】許可證字號:衛署醫器輸字第017818號
器材品名:華宇-腫瘤標記DR-70酵素免疫分析診斷試劑許可證字號:衛署醫器輸字第017818號註銷狀態:已註銷註銷日期:2018/04/25註...